LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lungHsiao‐Yen Ma, Ning Ding|Science Advances|2023Cited by 48
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidoneHsiao‐Yen Ma, Ning Ding|European Respiratory Journal|2022Cited by 23
Parallel 28: Liver Fibrosis: Basic and TranslationalLu Yao, Tatiana Kisseleva, Tong Wu et al.|Hepatology|2015Cited by 0